These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 16915065)

  • 1. Interobserver and intraobserver variability of standardized uptake value measurements in non-small-cell lung cancer.
    Marom EM; Munden RF; Truong MT; Gladish GW; Podoloff DA; Mawlawi O; Broemeling LD; Bruzzi JF; Macapinlac HA
    J Thorac Imaging; 2006 Aug; 21(3):205-12. PubMed ID: 16915065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interobserver variability among measurements of the maximum and mean standardized uptake values on (18)F-FDG PET/CT and measurements of tumor size on diagnostic CT in patients with pulmonary tumors.
    Huang YE; Chen CF; Huang YJ; Konda SD; Appelbaum DE; Pu Y
    Acta Radiol; 2010 Sep; 51(7):782-8. PubMed ID: 20707663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of the quantitative metabolic volumetric measurement on 18F-FDG PET/CT in Stage IV nonsurgical small-cell lung cancer.
    Liao S; Penney BC; Zhang H; Suzuki K; Pu Y
    Acad Radiol; 2012 Jan; 19(1):69-77. PubMed ID: 22142679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of PET standard uptake value and CT window-level thresholds for target delineation in CT-based radiation treatment planning.
    Hong R; Halama J; Bova D; Sethi A; Emami B
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):720-6. PubMed ID: 17293230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Standard uptake value predicts survival in non-small cell lung cancer.
    Okereke IC; Gangadharan SP; Kent MS; Nicotera SP; Shen C; DeCamp MM
    Ann Thorac Surg; 2009 Sep; 88(3):911-5; discussion 915-6. PubMed ID: 19699919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value predicts survival after lung cancer resection.
    Downey RJ; Akhurst T; Gonen M; Vincent A; Bains MS; Larson S; Rusch V
    J Clin Oncol; 2004 Aug; 22(16):3255-60. PubMed ID: 15310769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of interobserver reproducibility in quantitative 18F-FDG PET and CT measurements of tumor response to therapy.
    Jacene HA; Leboulleux S; Baba S; Chatzifotiadis D; Goudarzi B; Teytelbaum O; Horton KM; Kamel I; Macura KJ; Tsai HL; Kowalski J; Wahl RL
    J Nucl Med; 2009 Nov; 50(11):1760-9. PubMed ID: 19837757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The contribution of integrated PET/CT to the evolving definition of treatment volumes in radiation treatment planning in lung cancer.
    Ashamalla H; Rafla S; Parikh K; Mokhtar B; Goswami G; Kambam S; Abdel-Dayem H; Guirguis A; Ross P; Evola A
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1016-23. PubMed ID: 15979817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased standardized uptake value in the primary lesion predicts nodal or distant metastases at presentation in lung cancer.
    Sachs S; Bilfinger TV; Komaroff E; Franceschi D
    Clin Lung Cancer; 2005 Mar; 6(5):310-3. PubMed ID: 15845183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interobserver and Intraobserver Variability among Measurements of FDG PET/CT Parameters in Pulmonary Tumors.
    Büyükdereli G; Güler M; Şeydaoğlu G
    Balkan Med J; 2016 May; 33(3):308-15. PubMed ID: 27308075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Test-Retest Variability in Lesion SUV and Lesion SUR in
    Hofheinz F; Apostolova I; Oehme L; Kotzerke J; van den Hoff J
    J Nucl Med; 2017 Nov; 58(11):1770-1775. PubMed ID: 28473598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High fluorodeoxyglucose uptake on positron emission tomography in patients with advanced non-small cell lung cancer on platinum-based combination chemotherapy.
    Lee KH; Lee SH; Kim DW; Kang WJ; Chung JK; Im SA; Kim TY; Kim YW; Bang YJ; Heo DS
    Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4232-6. PubMed ID: 16857796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 18F-FDG PET for mediastinal staging of lung cancer: which SUV threshold makes sense?
    Hellwig D; Graeter TP; Ukena D; Groeschel A; Sybrecht GW; Schaefers HJ; Kirsch CM
    J Nucl Med; 2007 Nov; 48(11):1761-6. PubMed ID: 17942814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 18F-FDG uptake and EGFR mutations in patients with non-small cell lung cancer: a single-institution retrospective analysis.
    Na II; Byun BH; Kim KM; Cheon GJ; Choe du H; Koh JS; Lee DY; Ryoo BY; Baek H; Lim SM; Yang SH; Kim CH; Lee JC
    Lung Cancer; 2010 Jan; 67(1):76-80. PubMed ID: 19371962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated (18)F-FDG PET/CT and perfusion CT of primary colorectal cancer: effect of inter- and intraobserver agreement on metabolic-vascular parameters.
    Goh V; Shastry M; Engledow A; Kozarski R; Peck J; Endozo R; Rodriguez-Justo M; Taylor SA; Halligan S; Groves AM
    AJR Am J Roentgenol; 2012 Nov; 199(5):1003-9. PubMed ID: 23096172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FDG PET/CT interobserver agreement in head and neck cancer: FDG and CT measurements of the primary tumor site.
    Jackson T; Chung MK; Mercier G; Ozonoff A; Subramaniam RM
    Nucl Med Commun; 2012 Mar; 33(3):305-12. PubMed ID: 22227560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reproducibility of "intelligent" contouring of gross tumor volume in non-small-cell lung cancer on PET/CT images using a standardized visual method.
    Bayne M; Hicks RJ; Everitt S; Fimmell N; Ball D; Reynolds J; Lau E; Pitman A; Ware R; MacManus M
    Int J Radiat Oncol Biol Phys; 2010 Jul; 77(4):1151-7. PubMed ID: 20610039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Standardized Uptake Values in Normal Structures Between PET/CT and PET/MRI in a Tertiary Pediatric Hospital: A Prospective Study.
    Lyons K; Seghers V; Sorensen JI; Zhang W; Paldino MJ; Krishnamurthy R; Rohren EM
    AJR Am J Roentgenol; 2015 Nov; 205(5):1094-101. PubMed ID: 26496558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 18F-fluoro-2-deoxy-glucose uptake predicts clinical outcome in patients with gefitinib-treated non-small cell lung cancer.
    Na II; Byun BH; Kang HJ; Cheon GJ; Koh JS; Kim CH; Choe DH; Ryoo BY; Lee JC; Lim SM; Yang SH
    Clin Cancer Res; 2008 Apr; 14(7):2036-41. PubMed ID: 18381942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of different metabolic measurements with fluorine-18 fluorodeoxyglucose positron emission tomography in resectable non-small cell lung cancer: a two-center study.
    de Jong WK; van der Heijden HF; Pruim J; Dalesio O; Oyen WJ; Groen HJ
    J Thorac Oncol; 2007 Nov; 2(11):1007-12. PubMed ID: 17975491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.